Showing results (1-10 of 1,077) with videos related to
Sort By:
Pageof 108
Pathologie-Biologie|July 11, 2003
[Modeling 5-FU clearance during a chronomodulated infusion]F Kwiatkowski, V Chevalier, R Chevrier, et al.Pathologie-Biologie|June 9, 2005
[Stress, cancer and circadian rhythm of melatonin]F Kwiatkowski, C Abrial, F Gachon, et al.Pathologie-Biologie|June 9, 2005
[Therapeutic potential of melatonin in cancer treatment]C Abrial, F Kwiatkowski, R Chevrier, et al.Anticancer Research|February 24, 2001
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancerH Cure, V Chevalier, D Pezet, et al.Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.La Revue Du Praticien|April 1, 1990
[Adjuvant medical treatment]R Plagne, P Chollet, M Legros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancerH Curé, V Chevalier, A Adenis, et al.Hematology and Cell Therapy|August 1, 1997
Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemiaJ O Bay, M Fouassier, D Béal, et al.International Journal of Cancer|November 27, 1996
Circadian rhythm in toxic effects of cystemustine in mice: relevance for chronomodulated deliveryN Martineau-Pivoteau, F Levi, C Rolhion, et al.Pageof 108